Viewing Study NCT05668650

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:57 PM

Ignite Modification Date: 2025-12-29 @ 11:16 PM

Study NCT ID: NCT05668650

Status: RECRUITING

Last Update Posted: 2024-07-16

First Post: 2022-12-12

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Sponsor: Laboratorio Elea Phoenix S.A.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module